Kinase inhibitor drugs

A comprehensive resource on case studies of marketed kinase drugs and promising drug trialsSince the discovery of protein kinase activity in 1954, the field of protein kinase drug discovery has advanced dramatically. With the ongoing clinical success of the Bcr-Abl kinase inhibitor Gleevec in the tr...

Volledige beschrijving

Bibliografische gegevens
Formaat: Printed Book
Taal:Undetermined
Gepubliceerd in: New Jersey.
Onderwerpen:
Therapeutic use, Protein Kinase Inhibitors, Protein kinases, Pharmacology, Antineoplastic agents, Neoplasms, Inhibitors, Metabolism, Drug therapy, Protein Kinases, Drug Discovery, Antineoplastic Agent

Gelijkaardige items

Gelijkaardige items